Literature DB >> 12388360

Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells.

Jing Li1, Xa Dwight Johnson, Svetlana Iazvovskaia, Alan Tan, Anning Lin, Marc B Hershenson.   

Abstract

Ligation of the asialoGM1 Pseudomonas aeruginosa pilin receptor has been demonstrated to induce IL-8 expression in airway epithelial cells via an NF-kappaB-dependent pathway. We examined the signaling pathways required for asialoGM1-mediated NF-kappaB activation in IB3 cells, a human bronchial epithelial cell line derived from a cystic fibrosis (CF) patient, and C-38 cells, the rescued cell line that expresses a functional CF transmembrane regulator. Ligation of the asialoGM1 receptor with specific antibody induced greater IL-8 expression in IB3 cells than C-38 cells, consistent with the greater density of asialoGM1 receptors in CF phenotype cells. AsialoGM1-mediated activation of NF-kappaB, IkappaB kinase (IKK), and ERK was also greater in IB3 cells. With the use of genetic inhibitors, we found that IKK-beta and NF-kappaB-inducing kinase are required for maximal NF-kappaB transactivation and transcription from the IL-8 promoter. Finally, although ERK activation was required for maximal asialoGM1-mediated IL-8 expression, inhibition of ERK signaling had no effect on IKK or NF-kappaB activation, suggesting that ERK regulates IL-8 expression in an NF-kappaB-independent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388360     DOI: 10.1152/ajplung.00086.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  21 in total

Review 1.  Cystic fibrosis in adults: current and future management strategies.

Authors:  Brian M Morrissey; Bettina C Schock; Gregory P Marelich; Carroll E Cross
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 2.  Chronic Rhinosinusitis without Nasal Polyps.

Authors:  Seong Ho Cho; Dae Woo Kim; Philippe Gevaert
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jul-Aug

3.  Quercetin blocks airway epithelial cell chemokine expression.

Authors:  Suparna Nanua; Suzanna M Zick; Juan E Andrade; Umadevi S Sajjan; John R Burgess; Nicholas W Lukacs; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

4.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

Review 5.  Genetics of chronic rhinosinusitis: state of the field and directions forward.

Authors:  Joy Hsu; Pedro C Avila; Robert C Kern; M Geoffrey Hayes; Robert P Schleimer; Jayant M Pinto
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

6.  ATP-mediated activation of the NADPH oxidase DUOX1 mediates airway epithelial responses to bacterial stimuli.

Authors:  Agnes W Boots; Milena Hristova; David I Kasahara; Guido R M M Haenen; Aalt Bast; Albert van der Vliet
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

7.  The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease.

Authors:  David P Nichols; Assem G Ziady; Samuel L Shank; Jean F Eastman; Pamela B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

8.  Regulation of bacteria-induced intercellular adhesion molecule-1 by CCAAT/enhancer binding proteins.

Authors:  Lori J Manzel; Cecilia L Chin; Mark A Behlke; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

Review 9.  Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Authors:  David P Nichols; Michael W Konstan; James F Chmiel
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

Review 10.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.